Aprepitant

Chemical formula: C₂₃H₂₁F₇N₄O₃  Molecular mass: 534.427 g/mol  PubChem compound: 135413536

Therapeutic indications

Aprepitant is indicated for:

Prevention of nausea and vomiting associated with chemotherapy

Population group: only adults (18 years old or older)

Prevention nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prevention of nausea and vomiting associated with chemotherapy

Population group: only adolescents (12 years - 18 years old)

Prevention nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adolescents from the age of 12.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Aprepitant is contraindicated in the following cases:

Pimozide, terfenadine, astemizole, cisapride

at least one of
Pimozide
Terfenadine
Astemizole
Cisapride

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: EMEND Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈